What is CJC-1295 DAC
Global Peptide Sciences supplies CJC 1295 DAC in Australia, a long-acting growth hormone-releasing hormone (GHRH) analogue designed for laboratory research. Also referred to as CJC-1295 DAC, this peptide is studied for its extended activity profile and its influence on growth hormone and IGF-1 signalling pathways.
If you’re looking to buy CJC 1295 DAC peptides, our lab-grade product is third-party tested and supplied with full documentation for research use only.
What is CJC-1295 DAC
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analogue of growth hormone-releasing hormone (GHRH). In laboratory research, it is studied for its ability to stimulate growth hormone signalling pathways through activation of the GHRH receptor in the anterior pituitary.
The addition of the Drug Affinity Complex significantly extends the peptide’s half-life by allowing binding to circulating albumin, resulting in prolonged activity compared with shorter-acting GHRH analogues.
CJC 1295 DAC Peptide Benefits in Research
CJC-1295 DAC has been investigated in laboratory and clinical research involving:
- Growth hormone signalling pathways
- IGF-1 modulation
- Endocrine system studies
- Metabolic regulation research
- Recovery and tissue regeneration pathways
Studies have demonstrated that administration of CJC-1295 may increase circulating growth hormone and IGF-1 levels for extended periods following a single dose.
Product Information
- Peptide: CJC-1295 with DAC
- Class: GHRH analogue
- CAS: 446262-90-4
- Form: Lyophilised powder
- Purity: ≥98% (HPLC tested)
- Storage: Refrigerated after reconstitution
Why Choose CJC 1295 DAC?
Researchers studying long-acting GHRH analogues often select CJC 1295 DAC due to:
- Extended half-life compared to no-DAC variants
- Sustained growth hormone pathway research
- Reduced frequency requirements in experimental settings
- Stability in controlled laboratory protocols
This makes CJC-1295 DAC a preferred option in long-duration peptide research models.
Buy CJC 1295 with DAC in Australia
If you are searching for CJC 1295 DAC for sale in Australia, Global Peptide Sciences provides lab-grade peptides with COA verification and third-party purity testing.
You can buy CJC 1295 with DAC securely through our online platform. As part of our injectable research peptide range, all products are supplied as peptides with COA, ensuring transparency and research integrity.
Research Use Only
This compound is supplied strictly for laboratory research purposes. It is not approved for human consumption or therapeutic use.
Research Applications
GH & IGF-1 Pathway Research
CJC-1295 DAC is studied for:
- Pituitary stimulation of GH release
- Long-duration IGF-1 response modeling
- Enhanced GH pulse maintenance due to DAC attachment
Muscle Recovery & Body Composition
Researchers explore:
- Lean mass support through GH/IGF-1 pathways
- Improved recovery signaling and tissue repair response
- Fat reduction mechanisms linked to GH elevation
Previous Research Dosages Used
Dosage: 30mcg per kg of bodyweight (Example: 90kg × 30mcg = 2700mcg) for up to 16 weeks
Administered subcutaneously once or twice every 5 days.
For optimal alignment, administer in the evening to coincide with natural GH cycles.
Certificate of Analysis
Chemical Structure
Molecular FormulaC₁₆₅H₂₇₁N₄₇O₄₆
Molecular Weight~3647.7 g/mol
Purity≥99%
AppearanceWhite Lyophilized Powder
StorageStore at -20°C
FormLyophilized Peptide Compound
Key Structural Characteristics
- DAC modification enables prolonged action via albumin binding
- Long-duration GH stimulation supports weekly-style research protocols
- Used widely in GHRH/GH axis and IGF-1 research